Rocket Lab's Neutron delays to 2027, dilution risk from the $8B Iridium deal, and rich 50x sales valuation amid SpaceX IPO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results